Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 214

1.

Screening for imported diseases in an immigrant population: experience from a teaching hospital in Barcelona, Spain.

Bocanegra C, Salvador F, Sulleiro E, Sánchez-Montalvá A, Pahissa A, Molina I.

Am J Trop Med Hyg. 2014 Dec;91(6):1277-81. doi: 10.4269/ajtmh.14-0206. Epub 2014 Oct 20.

2.

Impact of influenza season and environmental factors on the clinical presentation and outcome of invasive pneumococcal disease.

Burgos J, Larrosa MN, Martinez A, Belmonte J, González-López J, Rello J, Pumarola T, Pahissa A, Falco V.

Eur J Clin Microbiol Infect Dis. 2015 Jan;34(1):177-186. doi: 10.1007/s10096-014-2221-9. Epub 2014 Aug 12.

PMID:
25109886
3.

Impact of prompt catheter withdrawal and adequate antimicrobial therapy on the prognosis of hospital-acquired parenteral nutrition catheter-related bacteraemia.

Rodríguez-Pardo D, Almirante B, Fernández-Hidalgo N, Pigrau C, Ferrer C, Planes AM, Alcaraz R, Burgos R, Pahissa A.

Clin Microbiol Infect. 2014 Nov;20(11):1205-10. doi: 10.1111/1469-0691.12703. Epub 2014 Jul 15.

4.

Unusual forms of subacute invasive pulmonary aspergillosis in patients with solid tumors.

Peghin M, Ruiz-Camps I, Garcia-Vidal C, Cervera C, Andreu J, Martin M, Gavaldá J, Gudiol C, Moreno A, Felip E, Pahissa A.

J Infect. 2014 Oct;69(4):387-95. doi: 10.1016/j.jinf.2014.03.018. Epub 2014 May 15.

PMID:
24844823
5.

Daptomycin is safe and effective for the treatment of gram-positive cocci infections in solid organ transplantation.

Len O, Montejo M, Cervera C, Fariñas MC, Sabé N, Ramos A, Cordero E, Torre-Cisneros J, Martín-Dávila P, Azanza JR, Pahissa A, Gavaldà J; DAPTOSOT (Daptomycin in Solid Organ Transplantation) Study Group.

Transpl Infect Dis. 2014 Aug;16(4):532-8. doi: 10.1111/tid.12232. Epub 2014 May 19.

PMID:
24834833
6.

Randomized trial of posaconazole and benznidazole for chronic Chagas' disease.

Molina I, Gómez i Prat J, Salvador F, Treviño B, Sulleiro E, Serre N, Pou D, Roure S, Cabezos J, Valerio L, Blanco-Grau A, Sánchez-Montalvá A, Vidal X, Pahissa A.

N Engl J Med. 2014 May 15;370(20):1899-908. doi: 10.1056/NEJMoa1313122.

7.

Prevention strategies for cytomegalovirus disease and long-term outcomes in the high-risk transplant patient (D+/R-): experience from the RESITRA-REIPI cohort.

Meije Y, Fortún J, Len Ó, Aguado JM, Moreno A, Cisneros JM, Gurguí M, Carratalà J, Muñoz P, Montejo M, Blanes M, Bou G, Pérez JL, Torre-Cisneros J, Ramos A, Pahissa A, Gavaldà J; Spanish Network for Research on Infection in Transplantation (RESITRA) and the Spanish Network for Research on Infectious Diseases (REIPI).

Transpl Infect Dis. 2014 Jun;16(3):387-96. doi: 10.1111/tid.12226. Epub 2014 May 8.

PMID:
24807640
8.

Etiology and mortality of spontaneous bacterial peritonitis in liver transplant recipients: a cohort study.

Pérez-Cameo C, Vargas V, Castells L, Bilbao I, Campos-Varela I, Gavaldà J, Pahissa A, Len O.

Liver Transpl. 2014 Jul;20(7):856-63. doi: 10.1002/lt.23889. Epub 2014 May 26.

9.

Usefulness of Strongyloides stercoralis serology in the management of patients with eosinophilia.

Salvador F, Sulleiro E, Sánchez-Montalvá A, Saugar JM, Rodríguez E, Pahissa A, Molina I.

Am J Trop Med Hyg. 2014 May;90(5):830-4. doi: 10.4269/ajtmh.13-0678. Epub 2014 Mar 10.

10.

Recommendations for screening of donor and recipient prior to solid organ transplantation and to minimize transmission of donor-derived infections.

Len O, Garzoni C, Lumbreras C, Molina I, Meije Y, Pahissa A, Grossi P; ESCMID Study Group of Infection in Compromised Hosts.

Clin Microbiol Infect. 2014 Sep;20 Suppl 7:10-8. doi: 10.1111/1469-0691.12557. Review.

11.

Daptomycin is effective as antibiotic-lock therapy in a model of Staphylococcus aureus catheter-related infection.

Meije Y, Almirante B, Del Pozo JL, Martín MT, Fernández-Hidalgo N, Shan A, Basas J, Pahissa A, Gavaldà J.

J Infect. 2014 Jun;68(6):548-52. doi: 10.1016/j.jinf.2014.01.001. Epub 2014 Jan 8.

PMID:
24412247
12.

Liver biopsy-related infection in liver transplant recipients: A current matter of concern?

Sánchez CL, Len O, Gavalda J, Bilbao I, Castells L, Gelabert MA, Allende H, Pahissa A.

Liver Transpl. 2014 May;20(5):552-6. doi: 10.1002/lt.23817. Epub 2014 Jan 27.

13.

Trypanosoma cruzi infection in a non-endemic country: epidemiological and clinical profile.

Salvador F, Treviño B, Sulleiro E, Pou D, Sánchez-Montalvá A, Cabezos J, Soriano A, Serre N, Gómez I Prat J, Pahissa A, Molina I.

Clin Microbiol Infect. 2014 Jul;20(7):706-12. doi: 10.1111/1469-0691.12443. Epub 2013 Dec 12.

14.

Risk factors for respiratory failure in pneumococcal pneumonia: the importance of pneumococcal serotypes.

Burgos J, Luján M, Larrosa MN, Fontanals D, Bermudo G, Planes AM, Puig M, Rello J, Falcó V, Pahissa A.

Eur Respir J. 2014 Feb;43(2):545-53. doi: 10.1183/09031936.00050413. Epub 2013 Jul 11.

15.

Reply to Gelfand et al and Solla.

Fernández-Hidalgo N, Almirante B, Pahissa A.

Clin Infect Dis. 2013 Sep;57(5):768-70. doi: 10.1093/cid/cit331. Epub 2013 May 23. No abstract available.

PMID:
23704124
16.

Immunogenicity of pandemic influenza A H1N1/2009 adjuvanted vaccine in pediatric solid organ transplant recipients.

Gavaldà J, Cabral E, Perez-Romero P, Len O, Aydillo T, Campins M, Quintero J, Peghin M, Nieto J, Charco R, Pahissa A, Cordero E; Spanish Network for the Research in Infectious Diseases (REIPI).

Pediatr Transplant. 2013 Jun;17(4):403-6. doi: 10.1111/petr.12084.

PMID:
23692602
17.

Ultrasensitive real-time PCR for the clinical management of visceral leishmaniasis in HIV-Infected patients.

Molina I, Fisa R, Riera C, Falcó V, Elizalde A, Salvador F, Crespo M, Curran A, López-Chejade P, Tebar S, Pérez-Hoyos S, Ribera E, Pahissa A.

Am J Trop Med Hyg. 2013 Jul;89(1):105-10. doi: 10.4269/ajtmh.12-0527. Epub 2013 Apr 29.

18.

Tropical diseases screening in immigrant patients with human immunodeficiency virus infection in Spain.

Salvador F, Molina I, Sulleiro E, Burgos J, Curran A, Van den Eynde E, Villar del Saz S, Navarro J, Crespo M, Ocaña I, Ribera E, Falcó V, Pahissa A.

Am J Trop Med Hyg. 2013 Jun;88(6):1196-202. doi: 10.4269/ajtmh.12-0714. Epub 2013 Mar 18.

19.

The increasing incidence of empyema.

Burgos J, Falcó V, Pahissa A.

Curr Opin Pulm Med. 2013 Jul;19(4):350-6. doi: 10.1097/MCP.0b013e3283606ab5. Review.

PMID:
23508113
20.

Epidemiology of Clostridium difficile infection and risk factors for unfavorable clinical outcomes: results of a hospital-based study in Barcelona, Spain.

Rodríguez-Pardo D, Almirante B, Bartolomé RM, Pomar V, Mirelis B, Navarro F, Soriano A, Sorlí L, Martínez-Montauti J, Molins MT, Lung M, Vila J, Pahissa A; Barcelona Clostridium difficile Study Group.

J Clin Microbiol. 2013 May;51(5):1465-73. doi: 10.1128/JCM.03352-12. Epub 2013 Feb 27.

21.

Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating enterococcus faecalis infective endocarditis.

Fernández-Hidalgo N, Almirante B, Gavaldà J, Gurgui M, Peña C, de Alarcón A, Ruiz J, Vilacosta I, Montejo M, Vallejo N, López-Medrano F, Plata A, López J, Hidalgo-Tenorio C, Gálvez J, Sáez C, Lomas JM, Falcone M, de la Torre J, Martínez-Lacasa X, Pahissa A.

Clin Infect Dis. 2013 May;56(9):1261-8. doi: 10.1093/cid/cit052. Epub 2013 Feb 7.

PMID:
23392394
22.

Management of tuberculosis in HIV-infected patients.

Curran A, Falcó V, Pahissa A, Ribera E.

AIDS Rev. 2012 Oct-Dec;14(4):231-46. Review.

PMID:
23258298
23.

[Invasive fungal infection in solid organ transplant].

Gavaldà J, Meije Y, Len Ó, Pahissa A.

Enferm Infecc Microbiol Clin. 2012 Dec;30(10):645-53. doi: 10.1016/j.eimc.2012.09.004. Epub 2012 Nov 3. Review. Spanish.

PMID:
23127517
24.

Immediate and long-term outcome of left-sided infective endocarditis. A 12-year prospective study from a contemporary cohort in a referral hospital.

Fernández-Hidalgo N, Almirante B, Tornos P, González-Alujas MT, Planes AM, Galiñanes M, Pahissa A.

Clin Microbiol Infect. 2012 Dec;18(12):E522-30. doi: 10.1111/1469-0691.12033. Epub 2012 Oct 18.

25.

Outcome of Clostridium difficile-associated disease in solid organ transplant recipients: a prospective and multicentre cohort study.

Len O, Rodríguez-Pardo D, Gavaldà J, Aguado JM, Blanes M, Borrell N, Bou G, Carratalà J, Cisneros JM, Fortún J, Gurguí M, Montejo M, Cervera C, Muñoz P, Asensio A, Torre-Cisneros J, Pahissa A; Spanish Research Network for the Study of Infection in Transplantation.

Transpl Int. 2012 Dec;25(12):1275-81. doi: 10.1111/j.1432-2277.2012.01568.x. Epub 2012 Oct 5.

26.

Influenza A H1N1/2009 infection in pediatric solid organ transplant recipients.

Gavaldà J, Cabral E, Alonso E, Perez-Romero P, Pérez A, Quintero J, Campins M, Vilalta R, Alonso A, Len O, Navarro M, Nieto J, Jara P, Charco R, Pahissa A, Cordero E.

Transpl Infect Dis. 2012 Dec;14(6):584-8. doi: 10.1111/tid.12005. Epub 2012 Sep 24.

PMID:
22998763
27.

Simplification to dual antiretroviral therapy including a ritonavir-boosted protease inhibitor in treatment-experienced HIV-1-infected patients.

Burgos J, Crespo M, Falcó V, Curran A, Navarro J, Imaz A, Domingo P, Podzamczer D, Mateo MG, Villar S, Van den Eynde E, Ribera E, Pahissa A.

J Antimicrob Chemother. 2012 Oct;67(10):2479-86. doi: 10.1093/jac/dks227. Epub 2012 Jun 22.

PMID:
22729925
28.

Neurological opportunistic infections and neurological immune reconstitution syndrome: impact of one decade of highly active antiretroviral treatment in a tertiary hospital.

Riveiro-Barciela M, Falcó V, Burgos J, Curran A, Van den Eynde E, Navarro J, Villar del Saz S, Ocaña I, Ribera E, Crespo M, Pahissa A.

HIV Med. 2013 Jan;14(1):21-30. doi: 10.1111/j.1468-1293.2012.01033.x. Epub 2012 Jun 25.

29.

Impact of the emergence of non-vaccine pneumococcal serotypes on the clinical presentation and outcome of adults with invasive pneumococcal pneumonia.

Burgos J, Falcó V, Borrego A, Sordé R, Larrosa MN, Martinez X, Planes AM, Sánchez A, Palomar M, Rello J, Pahissa A.

Clin Microbiol Infect. 2013 Apr;19(4):385-91. doi: 10.1111/j.1469-0691.2012.03895.x. Epub 2012 May 14.

30.

Evaluating the risk of transmission of infection from donor to recipient of a solid organ transplantation.

Len Ó, Ramos A, Pahissa A.

Enferm Infecc Microbiol Clin. 2012 Mar;30 Suppl 2:19-26. doi: 10.1016/S0213-005X(12)70078-2. Review.

PMID:
22542031
31.

[Lights and shadows of cytomegalovirus infection in solid organ transplantation].

Fariñas MC, Torre-Cisneros J, Pahissa A.

Enferm Infecc Microbiol Clin. 2011 Dec;29 Suppl 6:1-3. doi: 10.1016/S0213-005X(11)70048-9. Spanish.

PMID:
22541913
32.

Comment on: Changing epidemiology of central venous catheter-related bloodstream infections: increasing prevalence of Gram-negative pathogens.

Sordé R, Almirante B, Palomar M, Pahissa A.

J Antimicrob Chemother. 2012 Jun;67(6):1565-6; author reply 1566-7. doi: 10.1093/jac/dks054. Epub 2012 Feb 20. No abstract available.

PMID:
22354952
33.

Invasive pneumococcal disease in HIV-infected adults: clinical changes after the introduction of the pneumococcal conjugate vaccine in children.

Burgos J, Peñaranda M, Payeras A, Villoslada A, Curran A, Garau M, Riera M, Crespo M, Navarro J, Van den Eynde E, Planes AM, Ribera E, Pahissa A, Falcó V.

J Acquir Immune Defic Syndr. 2012 Jan 1;59(1):31-8. doi: 10.1097/QAI.0b013e31823d0f5f.

PMID:
22156821
34.

Valganciclovir as pre-emptive therapy for cytomegalovirus infection in allogeneic haematopoietic stem cell transplant recipients.

Ruiz-Camps I, Len O, de la Cámara R, Gurguí M, Martino R, Jarque I, Barrenetxea C, Díaz de Heredia C, Batlle M, Rovira M, de la Torre J, Torres A, Aguilar M, Espigado I, Martín-Dávila P, Bou G, Borrell N, Aguado JM, Pahissa A; Spanish Network for Research on Infection in Transplantation (RESITRA/REIPI). Spain.

Antivir Ther. 2011;16(7):951-7. doi: 10.3851/IMP1858.

PMID:
22024510
35.

GESITRA-SEIMC/REIPI recommendations for the management of cytomegalovirus infection in solid-organ transplant patients.

de la Torre-Cisneros J, Fariñas MC, Castón JJ, Aguado JM, Cantisán S, Carratalá J, Cervera C, Cisneros JM, Cordero E, Crespo-Leiro MG, Fortún J, Frauca E, Gavaldá J, Gil-Vernet S, Gurguí M, Len O, Lumbreras C, Marcos MÁ, Martín-Dávila P, Monforte V, Montejo M, Moreno A, Muñoz P, Navarro D, Pahissa A, Pérez JL, Rodriguez-Bernot A, Rumbao J, San Juan R, Santos F, Varo E, Zurbano F; GESITRA-SEIMC/REIPI.

Enferm Infecc Microbiol Clin. 2011 Dec;29(10):735-58. doi: 10.1016/j.eimc.2011.05.022. Epub 2011 Sep 17.

PMID:
21925772
36.

Abacavir coadministration does not interfere with the suppressive activity of ribavirin in an HCV replicon system.

Van den Eynde E, Quer J, Cubero M, Curran A, Homs M, Garcia-Cehic D, Falco V, Ribera E, Esteban JI, Pahissa A, Crespo M.

Antivir Ther. 2011;16(6):887-93. doi: 10.3851/IMP1861.

PMID:
21900721
37.

Effectiveness of antibiotic-lock therapy for long-term catheter-related bacteremia due to Gram-negative bacilli: a prospective observational study.

Funalleras G, Fernández-Hidalgo N, Borrego A, Almirante B, Planes AM, Rodríguez D, Ruiz I, Pahissa A.

Clin Infect Dis. 2011 Nov;53(9):e129-32. doi: 10.1093/cid/cir551. Epub 2011 Sep 2.

PMID:
21890750
38.

The spectrum of pneumococcal empyema in adults in the early 21st century.

Burgos J, Lujan M, Falcó V, Sánchez A, Puig M, Borrego A, Fontanals D, Planes AM, Pahissa A, Rello J.

Clin Infect Dis. 2011 Aug 1;53(3):254-61. doi: 10.1093/cid/cir354.

PMID:
21765073
39.

Management of refractory Pseudomonas aeruginosa infection in cystic fibrosis.

Sordé R, Pahissa A, Rello J.

Infect Drug Resist. 2011;4:31-41. doi: 10.2147/IDR.S16263. Epub 2011 Jan 25.

40.

Safety of liver transplantation with Chagas disease-seropositive donors for seronegative recipients.

Salvador F, Len O, Molina I, Sulleiro E, Sauleda S, Bilbao I, Castells L, Pont T, Gavaldà J, Pahissa A.

Liver Transpl. 2011 Nov;17(11):1304-8. doi: 10.1002/lt.22346.

41.

Emerging drugs for pneumococcal pneumonia.

Falcó V, Sánchez A, Pahissa A, Rello J.

Expert Opin Emerg Drugs. 2011 Sep;16(3):459-77. doi: 10.1517/14728214.2011.576669. Epub 2011 Apr 12. Review.

PMID:
21486118
42.

Prevalence of Candida bracarensis and Candida nivariensis in a Spanish collection of yeasts: comparison of results from a reference centre and from a population-based surveillance study of candidemia.

Cuenca-Estrella M, Gomez-Lopez A, Isla G, Rodriguez D, Almirante B, Pahissa A, Rodriguez-Tudela JL; Barcelona Candidemia Project Study Group.

Med Mycol. 2011 Jul;49(5):525-9. doi: 10.3109/13693786.2010.546373. Epub 2011 Jan 3.

PMID:
21198347
43.

Selection and viral load kinetics of an oseltamivir-resistant pandemic influenza A (H1N1) virus in an immunocompromised patient during treatment with neuraminidase inhibitors.

Antón A, López-Iglesias AA, Tórtola T, Ruiz-Camps I, Abrisqueta P, Llopart L, Marcos MÁ, Martínez MJ, Tudó G, Bosch F, Pahissa A, de Anta MT, Pumarola T.

Diagn Microbiol Infect Dis. 2010 Nov;68(3):214-9. doi: 10.1016/j.diagmicrobio.2010.08.003.

PMID:
20955912
44.

Current and potential usefulness of pneumococcal urinary antigen detection in hospitalized patients with community-acquired pneumonia to guide antimicrobial therapy.

Sordé R, Falcó V, Lowak M, Domingo E, Ferrer A, Burgos J, Puig M, Cabral E, Len O, Pahissa A.

Arch Intern Med. 2011 Jan 24;171(2):166-72. doi: 10.1001/archinternmed.2010.347. Epub 2010 Sep 27.

PMID:
20876397
45.

Prognosis of left-sided infective endocarditis in patients transferred to a tertiary-care hospital--prospective analysis of referral bias and influence of inadequate antimicrobial treatment.

Fernández-Hidalgo N, Almirante B, Tornos P, González-Alujas MT, Planes AM, Larrosa MN, Sambola A, Igual A, Pahissa A.

Clin Microbiol Infect. 2011 May;17(5):769-75. doi: 10.1111/j.1469-0691.2010.03314.x.

46.

Sex differences in native-valve infective endocarditis in a single tertiary-care hospital.

Sambola A, Fernández-Hidalgo N, Almirante B, Roca I, González-Alujas T, Serra B, Pahissa A, García-Dorado D, Tornos P.

Am J Cardiol. 2010 Jul 1;106(1):92-8. doi: 10.1016/j.amjcard.2010.02.019. Epub 2010 May 13.

PMID:
20609654
47.

Ability of treatment week 12 viral response to predict long-term outcome in genotype 1 hepatitis C virus/HIV coinfected patients.

Van den Eynde E, Tiraboschi JM, Tural C, Solà R, Mira JA, Podzamczer D, Jou A, Cañete N, Pineda JA, Pahissa A, Crespo M.

AIDS. 2010 Apr 24;24(7):975-82. doi: 10.1097/QAD.0b013e3283350f7c.

PMID:
20299963
48.

Predictors of candidaemia caused by non-albicans Candida species: results of a population-based surveillance in Barcelona, Spain.

Rodríguez D, Almirante B, Cuenca-Estrella M, Rodríguez-Tudela JL, Mensa J, Ayats J, Sanchez F, Pahissa A; Barcelona Candidemia Project Study Group.

Clin Microbiol Infect. 2010 Nov;16(11):1676-82. doi: 10.1111/j.1469-0691.2010.03208.x.

49.

Evaluation of linezolid, vancomycin, gentamicin and ciprofloxacin in a rabbit model of antibiotic-lock technique for Staphylococcus aureus catheter-related infection.

Fernández-Hidalgo N, Gavaldà J, Almirante B, Martín MT, Onrubia PL, Gomis X, Pahissa A.

J Antimicrob Chemother. 2010 Mar;65(3):525-30. doi: 10.1093/jac/dkp499. Epub 2010 Jan 18.

PMID:
20083550
50.

Impact of prior pneumococcal vaccination on clinical outcomes in HIV-infected adult patients hospitalized with invasive pneumococcal disease.

Imaz A, Falcó V, Peñaranda M, Jordano Q, Martínez X, Nadal C, Curran A, Planes AM, Dalmau D, Ribera E, Riera M, Ruiz de Gopegui E, Pahissa A.

HIV Med. 2009 Jul;10(6):356-63. doi: 10.1111/j.1468-1293.2009.00695.x. Epub 2009 Mar 11.

Supplemental Content

Loading ...
Support Center